Cell Source, Inc. (CLCS)
About Cell Source, Inc.
CELL SOURCE INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$4.5M
- Total assets
- $286.5K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Cell Source, Inc. (CLCS) Stock Price
- Reported a net loss of $4.5M.
- Trading 34% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cell Source, Inc..
Write a review
Cell Source, Inc.: frequently asked questions
Is Cell Source, Inc. an American company?
Cell Source, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Cell Source, Inc. headquartered?
Cell Source, Inc. is headquartered in New York, New York, United States.
Is Cell Source, Inc. publicly traded?
Yes — Cell Source, Inc. is a publicly traded company. Its stock trades under the ticker symbol CLCS on the OTC.
What does Cell Source, Inc. do?
Cell Source, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
